The slip
PARKINSON RECEIPTno. 7113
23 Oct 2026, 03:01 UTCmicroglia, braak
predictionNFATC2 in microglia tracks Braak Lewy-body stage
registered9738afb1078618c2
discovery-0.42 p=0.258 n=9
replication+0.39 p=0.304 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.42, p 0.258)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECT885939d4d63cdd4ae899eda9…
follows c9d4e9f7a88a…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 7113: NFATC2 in microglia, braak
- power
- full sample +0.01 (p 0.956, n 18), 95% CI -0.46 to +0.48. the interval is wide: not enough donors to tell.
- confounder
- adjusted for sex: -0.03 (p 0.915, n 18). does not hold up.
- composition
- microglia share of nuclei vs axis -0.11 (p 0.652); controlling for it: -0.03 (p 0.915, n 18). could be the mix.
- skeptic
- leave-one-out range -0.12 to +0.15, sign flips 7; without severely affected donors +0.01 (p 0.956, n 18). fragile.
- cell type
- no other cell group does better.
- axis
- no measure beats "tracks Braak Lewy-body stage" for NFATC2 in microglia.
case closed: nothing better to follow up.